Fig. 45From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease2D (left) and 3D (right) representation of interactions of compound C44o in the active site of AChE [53]Back to article page